Science & Enterprise subscription

Follow us on Twitter

  • When even PhRMA doesn't want to be a Trump campaign prop ... A Deal on Drug Prices Undone by White House Insistence… https://t.co/JjdVxOTVV6
    about 15 hours ago
  • A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $… https://t.co/D8kwt0ng5X
    about 16 hours ago
  • New post on Science and Enterprise: Mental Health Drug Company Raises $127.5M in IPO https://t.co/39Xea7VQpV #Science #Business
    about 16 hours ago
  • A test for SARS-CoV-2 viruses is shown in field tests to return diagnostic results in 90 minutes with accuracy comp… https://t.co/EuQIPTsL57
    about 20 hours ago
  • New post on Science and Enterprise: Point-of-Care Covid-19 Diagnostic Shows High Accuracy https://t.co/4l3pGrHx2o #Science #Business
    about 20 hours ago

Please share Science & Enterprise

Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Human T-cell

A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Gilead Acquires Cancer Therapy Biotech for $21B

Investment graphic

Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion. . . . → Read More: Gilead Acquires Cancer Therapy Biotech for $21B

Antibody Discovery Company Forms, Partners on Covid-19

Network pointer

A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19

Start-Up Developing Microbial Cancer Detection Tests

Blood sample vials

A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. . . . → Read More: Start-Up Developing Microbial Cancer Detection Tests

Trial Testing Lymphoma Drug to Treat Covid-19

SARS-Cov-2 virus

A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections. . . . → Read More: Trial Testing Lymphoma Drug to Treat Covid-19

Advanced Solid Tumor Precision Meds. Trial Begins

Brain tumor graphic

A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors. . . . → Read More: Advanced Solid Tumor Precision Meds. Trial Begins

Cancer Protein Therapy Biotech Raises $400M in IPO

Wall Street sign

A three year-old company developing protein-targeted cancer therapies with computational techniques is raising $400 million in its initial public offering of common stock. . . . → Read More: Cancer Protein Therapy Biotech Raises $400M in IPO

FDA Halts Off-the-Shelf Engineered T-Cell Trial

Stop sign

A company designing gene-edited T-cells as cancer therapies stopped its clinical trial of a treatment for multiple myeloma when a patient in the trial died. . . . → Read More: FDA Halts Off-the-Shelf Engineered T-Cell Trial

Ultrasound Boosts Cancer Gene Therapy

Cancer magnified

Ultrasound waves are shown in tests with lab mice to increase the uptake of a gene therapy that invokes the immune system in treating solid tumor cancers. . . . → Read More: Ultrasound Boosts Cancer Gene Therapy

Covid-19 Dual Therapy Drug Trial Okayed

SARS-Cov-2 viruses

A company developing an oral drug that treats both Covid-19 infections and overactive immune system reactions received regulatory approval for a later-stage clinical trial. . . . → Read More: Covid-19 Dual Therapy Drug Trial Okayed